Keywords: amgen, notes, delay, launch, aranesp, forecast, slight

Amgen notes delay in launch of Aranesp

Article | 01 May 2001

Print This

Amgen has forecast a slight delay in its launch schedule for Aranesp(darbepoetin alfa), a follow-up to its flagship anemia ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in